Francis Patrick Ostronic, Director at Cyclo Therapeutics, Inc. (CYTH), bought 5,000 shares at $2.04 ($10K) on 2022-05-20, disclosed to the SEC on 2022-05-23.
Open-market purchase of $10k CYTH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.00 | 12 | $24 | 0.2% |
| 2 | $2.04 | 4,988 | $10K | 99.8% |
| Total | $2.04 avg | 5,000 | $10K | 100% |
| Filing → |
| CYTH | BUY | 2022-01-24 | $8K | — | Filing → |
| CYTH | BUY | 2022-01-19 | $5K | — | Filing → |
| CYTH | BUY | 2022-01-18 | $7K | — | Filing → |